Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
about
Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combinationCardio classics revisited: focus on the role of amlodipineBlood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups.Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.Calcium channel blockers in cardiovascular pharmacotherapy.Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.Comparative effectiveness analysis of amlodipine/renin-angiotensin system blocker combinations.
P2860
Q35210547-77A432E7-8191-43F4-AE30-F7AF13B5DB9CQ35752993-AF312F79-3BFE-46B0-93B7-A7939BB67224Q36649903-33A81CB2-F069-4340-ABA0-743B5226DE94Q36941748-1964D814-C83D-4FE9-839C-9F9EB6F16ACCQ37560384-B07FD1AB-6F3A-4D24-BC9F-8D75C4760D4EQ37973584-EBAEE0A4-9FA9-4E77-9ECD-C6AC463CD237Q38056968-3102323E-1995-4EE4-AB59-9B7A23C0434CQ38145263-2CA55542-5613-4E32-B000-371C044C629DQ38156340-172C8594-F637-4C42-8C94-9A73519B55ECQ38215726-E6B28E25-C7AA-47B0-BD31-56F526A667F7Q38465638-BE809C40-3302-4315-955B-0B30FFDE42ACQ46296803-4CD3807F-F20C-41F9-8655-F5D1BB040CDD
P2860
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@ast
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@en
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@nl
type
label
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@ast
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@en
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@nl
prefLabel
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@ast
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@en
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@nl
P2093
P2860
P356
P1476
Long-term efficacy of a combin ...... a substudy of the COACH trial.
@en
P2093
P2860
P2888
P304
P356
10.1038/JHH.2010.16
P577
2010-03-04T00:00:00Z
P5875
P6179
1049809132